Lexmond AJ - Search Results

1

Challenging the two-minute tidal breathing challenge test.

Lexmond AJ, Hagedoorn P, Frijlink HW, de Boer AH. Lexmond AJ, et al. J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):380-6. doi: 10.1089/jamp.2012.1021. Epub 2013 Mar 19. J Aerosol Med Pulm Drug Deliv. 2013. PMID: 23509936

2

Devices and formulations for pulmonary vaccination.

Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WL. Tonnis WF, et al. Among authors: lexmond aj. Expert Opin Drug Deliv. 2013 Oct;10(10):1383-97. doi: 10.1517/17425247.2013.810622. Epub 2013 Jun 21. Expert Opin Drug Deliv. 2013. PMID: 23786408 Review.

3

Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testing.

Lexmond AJ, Hagedoorn P, van der Wiel E, Ten Hacken NH, Frijlink HW, de Boer AH. Lexmond AJ, et al. Eur J Pharm Biopharm. 2014 Jan;86(1):105-14. doi: 10.1016/j.ejpb.2013.06.027. Epub 2013 Oct 17. Eur J Pharm Biopharm. 2014. PMID: 24140941

4

Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects.

Lexmond AJ, van der Wiel E, Hagedoorn P, Bult W, Frijlink HW, ten Hacken NH, de Boer AH. Lexmond AJ, et al. Eur J Pharm Biopharm. 2014 Sep;88(1):148-52. doi: 10.1016/j.ejpb.2014.04.008. Epub 2014 Apr 26. Eur J Pharm Biopharm. 2014. PMID: 24780441

5

Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs.

Lexmond AJ, Singh D, Frijlink HW, Clarke GW, Page CP, Forbes B, van den Berge M. Lexmond AJ, et al. Pulm Pharmacol Ther. 2018 Apr;49:27-35. doi: 10.1016/j.pupt.2018.01.004. Epub 2018 Jan 10. Pulm Pharmacol Ther. 2018. PMID: 29331645 Free article. Review.

6

Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.

Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Vonk JM, Farenhorst MP, Ten Hacken NHT, Kerstjens HAM, van den Berge M. Cox CA, et al. Among authors: lexmond aj. BMC Pulm Med. 2019 Jan 28;19(1):23. doi: 10.1186/s12890-019-0783-0. BMC Pulm Med. 2019. PMID: 30691429 Free PMC article.

7

New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation.

Grasmeijer F, Lexmond AJ, van den Noort M, Hagedoorn P, Hickey AJ, Frijlink HW, de Boer AH. Grasmeijer F, et al. Among authors: lexmond aj. PLoS One. 2014 Jan 28;9(1):e87825. doi: 10.1371/journal.pone.0087825. eCollection 2014. PLoS One. 2014. PMID: 24489969 Free PMC article.

8

Effect of inhaler design variables on paediatric use of dry powder inhalers.

Lexmond AJ, Kruizinga TJ, Hagedoorn P, Rottier BL, Frijlink HW, de Boer AH. Lexmond AJ, et al. PLoS One. 2014 Jun 5;9(6):e99304. doi: 10.1371/journal.pone.0099304. eCollection 2014. PLoS One. 2014. PMID: 24901338 Free PMC article.

9

Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate.

Lexmond AJ, Boudewijn IM, Hagedoorn P, Schokker S, Cox CA, Vonk JM, Ten Hacken NHT, Frijlink HW, Vroegop SJ, van den Berge M. Lexmond AJ, et al. Am J Respir Crit Care Med. 2018 Feb 1;197(3):391-394. doi: 10.1164/rccm.201704-0715LE. Am J Respir Crit Care Med. 2018. PMID: 28650210 Clinical Trial. No abstract available.

10

Prerequisites for a dry powder inhaler for children with cystic fibrosis.

Lexmond AJ, Hagedoorn P, Frijlink HW, Rottier BL, de Boer AH. Lexmond AJ, et al. PLoS One. 2017 Aug 11;12(8):e0183130. doi: 10.1371/journal.pone.0183130. eCollection 2017. PLoS One. 2017. PMID: 28800360 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters